Archive for the ‘Media Production’ Category

« Older Entries

Supply Chain Security Highligted at the Annual TIDES Event in Las Vegas

Thursday, May 10th, 2012

SAFC will be onsite from May 20-23, 2012 at the Mandalay Bay in Las Vegas, Nevada for the annual TIDES Event hosted by IBC Life Sciences. We hope that you may be able to join SAFC at booth #206 and would also like to extend an invitation to a presentation at 4 p.m. on Tuesday, May 22, 2012. During this time, Senior Manufacturing Manager, Andreas Wolter will participate as a panel member for a presentation titled “The Oligo Supply Chain:  How Strong is the Weakest Link?” which will focus on new developments and solutions for supply chain security.

To set up a meeting with an SAFC representative, or for more information regarding SAFC’s nucleic acid solutions, contact us here. We also invite you to fill out this survey to receive a 20% discount code on your attendee registration.

We look forward to seeing you there!

Posted in Bioprocessing, CMOs, Industry Overview, Media Production, Quality, Supply Chain, Technologies | No Comments »

An API Regulations Update from the ICH Q3D Metal Impurities Workshop

Friday, April 20th, 2012

As SAFC Live previously reported, the  ICH Q3D Metal Impurities Workshop was held from April 4-5, 2012 at the Marriott Bethesda North Hotel in Bethesda, Maryland. The program focused on the new limits for element impurities in drug products and how they may impact businesses in the pharma industry. On day one, SAFC Quality Assurance Director, Patty Benson, participated in a panel titled “Perspectives From Active Pharmaceutical Ingredient (API) Suppliers”, along with a lineup of speakers from industry colleagues, the IPEC-Americas, CHPA and SOCMA’s Bulk Pharmaceutical Task Force (BPTF). The panel talked about draft guidelines and data implications, and their impact on pharmaceuticals. Patty’s input from an API maker’s perspective was complemented with an excipient user perspective from Janeen Skutnik-Wilkinson, Director of Quality and Regulatory Policy at Pfizer Inc. and an excipient maker perspective from David Schoneker, Director of Global Regulatory Affairs at Colorcon.

Patty’s presentation in the “Perspectives From Active Pharmaceutical Ingredient (API) Suppliers” panel is available for reference here: Q3D BPTF 0412.

To learn more about SAFC, please click here.

Posted in APIs, Facilities, HPAPIs, Industry Overview, Media Production, Quality, Regulatory, Supply Chain | No Comments »

A Deeper Look Into the New CHOZN® Platform System for Recombinant Protein Production

Friday, April 13th, 2012

On Wednesday, April 11th, SAFC announced the launch of the CHOZN cell platform system for biopharma producers to create and scale up high producing clones more quickly and easily. Here, SAFC Live speaks to Kevin Kayser, Associate Director of Cell Sciences and Development at SAFC, about why the platform was developed, and what it can do.

(more…)

Posted in Bioprocessing, Cell biology, CMOs, Industry Overview, Media Production, ZFN | No Comments »

BREAKING NEWS: SAFC Launches CHOZN® Platform System to Accelerate Recombinant Protein Drug Development

Wednesday, April 11th, 2012

Today, SAFC announced the launch of the CHOZN® Platform System to accelerate recombinant protein drug development. The new platform allows faster and simpler selection of high producing clones for use in recombinant protein drugs, as well as facilitating a more efficient scale-up process. The full press release is available below.

(more…)

Posted in Cell biology, CMOs, Industry Overview, Media Production, Quality, Regulatory, Technologies, ZFN | No Comments »

Nature Method Award Celebrates SAFC’s ZFN Technology

Monday, April 9th, 2012

For the third year in a row, SAFC is the proud winner of a Nature Method award. The awards, presented annually by Nature.com, highlight revolutionary methods in genome and cell products and manufacturing. In 2012, SAFC received the award for their ZFN technology. An abstract highlighting the winning presentation follows: http://www.nature.com/nmeth/journal/v9/n1/full/nmeth.1805.html.

To learn more about SAFC’s Cell Design Studio, which includes ZFN technologies and services, please click here.

To directly contact SAFC for more information about products and services, please click here.

Posted in Cell biology, CMOs, Industry Overview, Media Production, Technologies, ZFN | No Comments »

BREAKING NEWS: Sigma-Aldrich Acquires Research Organics to Strengthen Portfolio of PharmaGrade Raw Materials

Tuesday, April 3rd, 2012

Yesterday, Sigma-Aldrich announced the acquisition of Research Organics, a leading supplier of biochemicals for use in various bioprocessing, biotechnology and diagnostic applications. The addition means that SAFC will now be able to offer dual sourced buffers, as well as an expansion of the raw materials catalog of products. As executives for both companies noted, the acquisition has been made with an end goal of increasing quality of service and capacity to partner with customers on both standard and custom project solutions.

To read the full press release, please click below. To learn more about SAFC’s line of PharmaGrade Products, please click here.

(more…)

Posted in Bioconjugation, biology, Bioprocessing, Cell biology, CMOs, Continuous Processing - Microreators, Diagnostics, Fine Chemicals, HPAPIs, Industry Overview, Media Production, Quality, Regulatory, Supply Chain, Technologies | No Comments »

SAFC Presents at the Upcoming ICH Q3D Metal Impurities Workshop in Bethesda, Maryland

Monday, April 2nd, 2012

From April 4-5, 2012, delegates will gather at the Marriott Bethesda North Hotel in Bethesda, Maryland for the two day ICH Q3D Metal Impurities Workshop that will feature a program focused on the new limits for element impurities in drug products and how they may impact businesses in the pharma industry.

On Wednesday, April 4th at 9am, SAFC Quality Assurance Director, Patty Benson, will participate in a panel titled “Perspectives From Active Pharmaceutical Ingredient (API) Suppliers”, along with a lineup of speakers from industry colleagues, the IPEC-Americas, CHPA and SOCMA’s Bulk Pharmaceutical Task Force (BPTF) to discuss the draft guidelines and implications data will have, as well as the impact on pharmaceuticals. Patty’s input from an API maker’s perspective will be complemented with an excipient user perspective from Janeen Skutnik-Wilkinson, Director of Quality and Regulatory Policy at Pfizer Inc. and an excipient maker perspective from David Schoneker, Director of Global Regulatory Affairs at Colorcon.

We hope to see you there to learn, network and exchange information amongst industry peers. To learn more about registration for the event, please click here. To learn more about SAFC, please click here.

Posted in APIs, Bioconjugation, Bioprocessing, Cell biology, CMOs, Fermentation, HPAPIs, Industry Overview, Media Production, Quality, Regulatory | No Comments »

« Older Entries